Zymeworks In Connection With Entry Into Termination, On Sept 18, 2023, Co's Unit, Beigene Entered Into 3rd Amendment To License & Collaboration Deal; Unit Eligible To Receive Tiered Royalties Ranging High Single Digit Percentages Up To 19.5% On Net Sales
Portfolio Pulse from Benzinga Newsdesk
Zymeworks' unit, Beigene, has entered into the 3rd amendment to its license and collaboration deal on September 18, 2023. The unit is now eligible to receive tiered royalties ranging from high single-digit percentages up to 19.5% on net sales.
September 21, 2023 | 8:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Zymeworks' unit Beigene's amended license deal could lead to increased revenues through higher royalties, potentially boosting ZYME's financial performance.
The amendment to the license and collaboration deal allows Beigene, a unit of Zymeworks, to receive higher royalties on net sales. This could lead to increased revenues for Zymeworks, potentially improving its financial performance and positively impacting its stock price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100